Literature DB >> 3005191

Epstein-Barr virus specific antibodies in patients with coeliac disease.

S Harada, J Greally, J Davis, N Synder, F Stevens, C McCarthy, D T Purtilo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3005191     DOI： 10.1007/bf02937215

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  18 in total

1.  Gluten-sensitive enteropathy: synthesis of antigliadin antibody in vitro.

Authors:  Z M Falchuk; W Strober
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

2.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

3.  Investigation of possible intestinal peptidase deficiency in coeliac disease.

Authors:  H J Cornell; R R Townley
Journal:  Clin Chim Acta       Date:  1973-01-10       Impact factor: 3.786

4.  Immunodeficiency in humans as a risk factor in the development of malignancy.

Authors:  A H Filipovich; B D Spector; J Kersey
Journal:  Prev Med       Date:  1980-03       Impact factor: 4.018

5.  Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry.

Authors:  D T Purtilo; K Sakamoto; V Barnabei; J Seeley; T Bechtold; G Rogers; J Yetz; S Harada
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

6.  Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.

Authors:  A K Saemundsen; D T Purtilo; K Sakamoto; J L Sullivan; A C Synnerholm; D Hanto; R Simmons; M Anvret; R Collins; G Klein
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

7.  Abnormal anti-Epstein Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk.

Authors:  K Sakamoto; J K Seeley; T Lindsten; J Sexton; J Yetz; M Ballow; D T Purtilo
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

8.  Antibodies to Epstein-Barr virus-specific antigens in patients with hairy-cell leukemia.

Authors:  K Sakamoto; M Aiba; I Katayama; J L Sullivan; R E Humphreys; D T Purtilo
Journal:  Int J Cancer       Date:  1981       Impact factor: 7.396

9.  The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation.

Authors:  D W Hanto; K Sakamoto; D T Purtilo; R L Simmons; J S Najarian
Journal:  Surgery       Date:  1981-08       Impact factor: 3.982

Review 10.  Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model.

Authors:  D T Purtilo
Journal:  Adv Cancer Res       Date:  1981       Impact factor: 6.242
View more
  1 in total

1.  CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.

Authors:  Michael P Pender
Journal:  Autoimmune Dis       Date:  2012-01-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.